ECO Animal Health Statement re ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation d...
December 03 2018 - 1:00AM
UK Regulatory
TIDMEAH
ECO Animal Health Group plc
(AIM: EAH)
ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine
antimicrobial novel formulation development and licencing deal
ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO
Animal Health Group plc, is pleased to announce that it has entered
a development and licensing deal with Agrinnovation and Yissum
Research Development Company of the Hebrew University of Jerusalem
Ltd., State of Israel.
This deal, based on a number of milestone payments, allows ECO
to licence patented research related innovations leading to the
development of a unique long acting injectable florfenicol product
to treat swine bacterial respiratory disease with a single dose.
Florfenicol is an antimicrobial used only in veterinary medicine
and the product will complement both the spectrum of activity and
the oral route of administration of Aivlosin ®, ECO's patented
molecule for the treatment of economically important diseases in
pigs and poultry.
Peter Lawrence, Non-executive Chairman of ECO Animal Health
Group plc said, "Recent market research has indicated that
treatment for respiratory disease accounts for over 40% of
antimicrobial treatments in finishing pigs. We are delighted to
have entered this collaboration with Agrinnovation ".
Dr. Ido Schechter, Agrinnovation CEO said, "We are excited to
enter this collaboration with ECO, which underscores the promise of
agricultural research at Hebrew University and supports our vision
of sustainable agriculture around the world through collaborations
between industry and academic organizations."
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contacts:
ECO Animal Health Group plc
Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
-----------------------------------------------------
About ECO Animal Health Ltd
ECO Animal Health based in London U.K. is a leader in the
development, registration and marketing of pharmaceutical products
for global animal health markets. Its products for these growth
markets promote well-being in animals and include the novel
antimicrobial, Aivlosin®, as well as a range of generic therapeutic
products.
About Agrinnovation (Yissum) L.P.
Agrinnovation is a limited partnership affiliated with Yissum
Research Development Company of the Hebrew University of Jerusalem
Ltd., State of Israel, entitled to invest in, develop and
commercialise projects in the field of veterinary medicine based on
inventions generated by scientists of the University.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181202005043/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
December 03, 2018 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024